| Year |
Citation |
Score |
| 2021 |
Lam H, McNeil LK, Starobinets H, DeVault VL, Cohen RB, Twardowski P, Johnson ML, Gillison ML, Stein MN, Vaishampayan UN, DeCillis AP, Foti JJ, Vemulapalli V, Tjon E, Ferber K, et al. An empirical antigen selection method identifies neoantigens that either elicit broad anti-tumor T cell responses or drive tumor growth. Cancer Discovery. PMID 33504579 DOI: 10.1158/2159-8290.CD-20-0377 |
0.389 |
|
| 2020 |
Cohen RB, Twardowski P, Johnson ML, Gillison ML, Stein MN, Vaishampayan UN, McNeil L, Shainheit M, DeOliveira D, Jain M, Price J, Hernandez R, DeCillis AP, Singh N, Flechtner J, et al. GEN-009, a neoantigen vaccine containing ATLAS selected neoantigens, to generate broad sustained immunity against immunogenic tumor mutations and avoid inhibitory peptides. Journal of Clinical Oncology. 38: 3107-3107. DOI: 10.1200/jco.2020.38.15_suppl.3107 |
0.335 |
|
| 2011 |
Attig S, Price L, Janetzki S, Kalos M, Pride M, McNeil L, Clay T, Yuan J, Odunsi K, Hoos A, Romero P, Britten CM. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols. Journal of Translational Medicine. 9: 108. PMID 21745365 DOI: 10.1186/1479-5876-9-108 |
0.386 |
|
| 2004 |
Ryan KR, McNeil LK, Dao C, Jensen PE, Evavold BD. Modification of peptide interaction with MHC creates TCR partial agonists Cellular Immunology. 227: 70-78. PMID 15051516 DOI: 10.1016/J.Cellimm.2004.01.003 |
0.354 |
|
| 2003 |
McNeil LK, Evavold BD. TCR reserve: A novel principle of CD4 T cell activation by weak ligands Journal of Immunology. 170: 1224-1230. PMID 12538680 DOI: 10.4049/Jimmunol.170.3.1224 |
0.637 |
|
| 2002 |
McNeil LK, Evavold BD. Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation Proceedings of the National Academy of Sciences of the United States of America. 99: 4520-4525. PMID 11904393 DOI: 10.1073/Pnas.072673899 |
0.667 |
|
| Show low-probability matches. |